\
&
Contact us
\
&
Contact us
This was 4 months ago
LocationHybrid event - Online and in Madrid (Spain)
ProgrammesThis Brokerage Event brings together SMEs, larger companies, researchers, authorities, end-users and other relevant institutions working in the field of security and defence to facilitate the formation of consortia for Horizon Europe Cluster 3 "Civil Security for Society" calls for proposals 2025.
This is an hybrid event celebrated in the framework of the in the International Fair of Defence and Security FEINDEF 2025. Meetings will take place in a dedicated space in IFEMA (Madrid) on the 12th, 13th and 14th May, with the possibility to participate remotely for those interested entities that are unable to travel to Madrid. Participants will arrange 20 minutes meetings beforehand through this website at their convenience.
This is a unique opportunity to generate new strategic contacts and foster technological cooperation in security and defence at the international level.
Furthermore, the Infoday for Horizon Europe Cluster 3 - Civil Security for Society will be held in collaboration with CDTI and Cluster 3 National Contact Points (NCPs). NCPs will also be available during the Brokerage Event to host meetings and advice on project ideas.
Register now to secure your place at this Brokerage Event and make new connections in security and defence!
*For onsite participants, meetings will take place
On Monday (12th) and Wednesday (14th) at Fundación madri+d Booth, located in Pavillion 8, Stand F17.
On Tuesday (13th) at Centro de Convenciones Norte, Room 101, right after the INFODAY for Cluster 3 "Civil Security for Society".
*Access for those participants registered onsite will be granted by madri+d. To obtain your badge, please access https://registro.feindefevent.com/feindef2025/es/register/RegisterPage/VisitorsInvited and use the following Invitation code: FFVY5BQ3.
Participation is free of charge.
More info and registration on: https://www.b2match.com/e/feindef-2025
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
